Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2010 Sep 6:3:169-81.
doi: 10.2147/JPR.S9243.

Investigational pharmacology for low back pain

Affiliations

Investigational pharmacology for low back pain

Avinash K Bhandary et al. J Pain Res. .

Abstract

Study design: Review and reinterpretation of existing literature.

Objective: This review article summarizes the anatomy and pathogenesis of disease processes that contribute to low back pain, and discusses key issues in existing therapies for chronic low back pain. The article also explains the scientific rationale for investigational pharmacology and highlights emerging compounds in late development.

Results/conclusion: While the diverse and complex nature of chronic low back pain continues to challenge clinicians, a growing understanding of chronic low back pain on a cellular level has refined our approach to managing chronic low back pain with pharmacology. Many emerging therapies with improved safety profiles are currently in the research pipeline and will contribute to a multimodal therapeutic algorithm in the near future. With the heterogeneity of the patient population suffering from chronic low back pain, the clinical challenge will be accurately stratifying the optimal pharmacologic approach for each patient.

Keywords: drugs; investigational; low back pain; pharmacology.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Pharmacology reviewed.
Figure 2
Figure 2
Zygapophyseal joint.
Figure 3
Figure 3
The cyclooxygenase (COX) pathway.

Similar articles

Cited by

References

    1. Freynhagen R, Baron R. The evaluation of neuropathic components in low back pain. Curr Pain Headache Rep. 2009;13(3):185–190. - PubMed
    1. Deyo R, Mirza S, Turner J, Martin B. Overtreating chronic back pain: time to back off? J Am Board Fam Med. 2009;22(1):62–68. - PMC - PubMed
    1. Dagenais S. A systematic review of low back pain cost of illness studies in the united states and internationally. Spine J. 2008;8(1):8–20. - PubMed
    1. Borenstein D. Does osteoarthritis of the lumbar spine cause chronic low back pain? Curr Rheumatol Rep. 2004;6(1):14–19. - PubMed
    1. Altman R. Practical considerations for the pharmacologic management of osteoarthritis. Am J Manag Care. 2009;15(8):236–243. - PubMed

LinkOut - more resources